Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis.

Autor: Ibnou Zekri Lassout, Nabila, Goyal, Vishal, Krantz, Edrich, Simon, Francois, Neven, Anouk, Eriksson, Johanna, Saayman, Amaria, Satam, Vijay, Ruffell, Carol, Victor, Sarika, Chenel, Marylore, Celebic, Aljosa, Caplain, Henri, Gillon, Jean‐Yves, Deshmukh, Abhijit, Antarkar, Amit, Sjögren, Eric, Ribeiro, Isabela

Publikováno v: CTS: Clinical & Translational Science; Sep2024, Vol. 17 Issue 9, p1-11, 11p

Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.

Autor: Ibnou Zekri Lassout N; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Goyal V; Drugs for Neglected Diseases Initiative, New York, New York, USA., Krantz E; FARMOVS, Bloemfontein, South Africa., Simon F; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Neven A; Competence Center for Methodology and Statistics (CCMS), Luxembourg Institute of Health, Strassen, Luxembourg., Eriksson J; Pharmetheus, Uppsala, Sweden., Saayman A; FARMOVS, Bloemfontein, South Africa., Satam V; Drugs for Neglected Diseases initiative, New Delhi, India., Ruffell C; DNDi GARDP Southern Africa, Cape Town, South Africa., Victor S; FARMOVS, Bloemfontein, South Africa., Chenel M; Pharmetheus, Uppsala, Sweden., Celebic A; Competence Center for Methodology and Statistics (CCMS), Luxembourg Institute of Health, Strassen, Luxembourg., Caplain H; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Gillon JY; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Deshmukh A; Viatris, Hyderabad, India., Antarkar A; Viatris, Hyderabad, India., Sjögren E; Pharmetheus, Uppsala, Sweden., Ribeiro I; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e13908.